Informa (LON:INF) Stock Crosses Above 200-Day Moving Average – Should You Sell?

Posted by Francis Steltz on Jul 31st, 2026

Informa plc (LON:INF – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 832.56 and traded as high as GBX 911.80. Informa shares last traded at GBX 907.82, with a volume of 137,010,656 shares.

Trending Headlines about Informa

Here are the key news stories impacting Informa this week:

Positive Sentiment: Higher full-year guidance: Informa raised its fiscal-year outlook as first-half growth strengthened, signaling confidence in continued demand across its events, publishing and digital businesses. Informa lifts FY guidance as H1 growth strengthens
Positive Sentiment: Healthy B2B events performance: The B2B Live Events division delivered 8% underlying revenue growth in the first half. Although some IMEA events were rescheduled, the underlying trend indicates resilient corporate and professional-event demand. Informa H1 2026 Trading Update
Positive Sentiment: Broker support increased: Berenberg raised its price target from GBX 965 to GBX 1,040 and initiated or reaffirmed a “buy” rating. Deutsche Bank also reaffirmed “buy” with a GBX 1,140 target, implying substantial upside to the recent trading level. Broker views from Digital Look
Neutral Sentiment: Informa reported quarterly earnings of GBX 26.70 per share. The result provides additional financial confirmation, but the raised outlook and forward guidance are likely more important to the market than the headline quarterly figure.
Neutral Sentiment: Recent partnerships involving Informa TechTarget, BrightTALK and the fashion supply chain expand the company’s industry reach, but their near-term financial impact is unclear.

Analyst Ratings Changes

INF has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,140 price objective on shares of Informa in a report on Friday. Citigroup dropped their price target on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Berenberg Bank increased their price target on Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a research note on Friday. Finally, JPMorgan Chase & Co. cut their price target on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of GBX 1,095.

Read Our Latest Research Report on INF

Informa Trading Down 1.1%

The company has a market cap of £11.33 billion, a P/E ratio of 1,129.33, a price-to-earnings-growth ratio of 0.75 and a beta of 0.69. The company has a quick ratio of 1.70, a current ratio of 0.44 and a debt-to-equity ratio of 61.56. The firm’s 50-day moving average price is GBX 862.18 and its 200-day moving average price is GBX 832.65.

Informa (LON:INF – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 1.64% and a return on equity of 0.87%. As a group, equities research analysts expect that Informa plc will post 59.3240265 earnings per share for the current fiscal year.

Insider Buying and Selling at Informa

In related news, insider Gareth Wright bought 222 shares of the company’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average price of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Stephen A. Carter purchased 222 shares of the business’s stock in a transaction dated Wednesday, May 20th. The stock was bought at an average cost of GBX 809 per share, with a total value of £1,795.98. Corporate insiders own 0.39% of the company’s stock.

Informa Company Profile

(Get Free Report)

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.